Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
35
CardioMech MVRS
Cardiovascular Institute of Los Robles Health System
Thousand Oaks, California, United States
Northwestern University
Evanston, Illinois, United States
Ascension St. Francis via Christi
Wichita, Kansas, United States
Freedom from serious adverse events determined to be related to the CardioMech MVRS device or procedure
Time frame: 30 days
Change in MR grade
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mayo Clinic
Rochester, Minnesota, United States
CentraCare Heart & Vascular Center
Saint Cloud, Minnesota, United States
NYU Langone
New York, New York, United States
Atrium Health Sanger Heart and Vascular Institute
Charlotte, North Carolina, United States
The Christ Hospital
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Ascension St. Thomas West
Nashville, Tennessee, United States
...and 2 more locations